Article Text

FDA Issues New Clinical Research Warning Letters

Statistics from

On June 5 and 11, the U.S. Food and Drug Administration (FDA) issued two new warning letters for alleged violations of FDA regulations involving clinical research, according to a press release from the Arent Fox Law Firm of Washington, DC. The notifications were the first FDA warning letters issued in almost 1 year. Reflecting the ongoing and increasing focus …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.